Xuduan Zhuanggu Jiaonang (续断壮骨胶囊)续断壮骨胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

续断总皂苷是一种在国家药监局注册认定的药品。标注生产企业为浙江迪耳药业有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司、浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司、浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 续断壮骨胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 浙江迪耳药业有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司, 浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司, 浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 续断壮骨胶囊Recorded Chinese name: 续断壮骨胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 每粒装0.29g(含续断总皂苷提取物0.28g)Recorded Chinese specification: 每粒装0.29g(含续断总皂苷提取物0.28g)

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 浙江迪耳药业有限公司Chinese legal name: 浙江迪耳药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z20070054

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z20070054

Manufacturer

Chinese legal name: 浙江迪耳药业有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z20070054

生产企业

浙江迪耳药业有限公司(国产)

功能主治

补肾壮骨。用于原发性骨质疏松症属肝肾不足证,症见腰背疼痛、腰膝酸软、下肢疼痛、下肢痿弱、步履艰难等。

用法用量

口服。一次2粒,一日3次。疗程6个月。

不良反应

1.偶见腹胀,胃脘不适,便秘,烦燥,口干,牙龈肿痛。|2.临床试验中偶见服药后试验室检查有ALT轻度升高。

禁忌

对本品过敏者禁用。

注意事项

1.肝功能异常者慎用。|2.目前尚无孕妇及哺乳期妇女临床试验资料。

贮藏

密封,置阴凉处。

规格

每粒装0.29g(含续断总皂苷提取物0.28g)

证据Evidence

  • 批准文号: 国药准字Z20070054
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.